卡维地洛:在延缓肝硬化从代偿期到失代偿期病情进展中的作用 episode artwork

EPISODE · Jul 27, 2026 · 12 MIN

卡维地洛:在延缓肝硬化从代偿期到失代偿期病情进展中的作用

from 消化肝病前沿资讯

本期播客围绕肝硬化从代偿期到失代偿期的关键转折展开,深入探讨卡维地洛在延缓病情进展中的作用。从2019年PREDESCI试验到2026年最新临床研究,解析该药降低腹水发生率、死亡率的证据,同时剖析研究局限性、安全性及最佳用药方案,强调循证医学与综合治疗的重要性。00:06肝硬化代偿期与失代偿期00:27PREDESCI试验核心发现解读01:29荟萃分析证实降低死亡率02:36临床指南用药指征说明03:29新研究聚焦腹水治疗窗口期04:13新研究大幅降低死亡风险05:11研究分组病因差异的影响06:05酒精监测缺失致结果偏差07:08开放标签设计引偏倚问题07:46卡维地洛安全性与温和调控08:54用药剂量与综合治疗方案09:37数字工具应用存偏倚风险10:39循证医学稳扎稳打前进11:33所以说,医学研究的复杂性就在这里

Episode metadata supplied by the publisher feed · Published Jul 27, 2026

Embed this episode

Ready to play

卡维地洛:在延缓肝硬化从代偿期到失代偿期病情进展中的作用

0:00 12:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 消化肝病前沿资讯?

This episode is 12 minutes long.

When was this 消化肝病前沿资讯 episode published?

This episode was published on July 27, 2026.

Can I download this 消化肝病前沿资讯 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!